J1072 NDC Crosswalk, Billing Units, ASP Payment & Medicare Reimbursement

📋 J1072 summary

J1072 is a HCPCS Level II J-code used to bill testosterone, azmiro, billed per 1 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Brand names associated with J1072: Azmiro

Code J1072 Billing unit 1 MG Payment limit $1.296/unit NDC-Crosswalk 2 Quarter Q3 2026 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ1072

DescriptorInj, testosterone, azmiro

Billing unit1 MG

Payment limit / unit$1.296

Est. ASP / unit$1.223 est.

Mapped NDCs2

Data periodQ3 2026

Last updated2026-08-20

🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026

📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).

Medicare payment limit / unit

$1.296

Est. ASP / unit

$1.223 est.

Est. after 2% sequester

$1.270

HCPCS dosage

1 MG

The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J1072 = 1 mg. Enter a regimen to convert dose → billing units and project a full course.

Dose per administration (mg) Frequency — every days Number of doses NDC / package billed (optional)

Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J1072 WITH EST. MEDICARE PAY

2 NDCs map to J1072. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($1.296/unit) × that package's bill units.

NDC (11-digit)	Drug	Labeler	Package	Strength	Bill units	Est. pay / pkg	NADAC / unit	Status	Source
24338-0055-01	AZMIRO TESTOSTERONE CYPIONATE 200 mg/mL INJECTION, SOLUTION	Azurity	1 SYRINGE, GLASS in 1 CARTON (24338-055-01...	200 mg/mL	200	$259.20	—	● Active	CMS + PDAC
24338-0056-01	AZMIRO TESTOSTERONE CYPIONATE 200 mg/mL INJECTION, SOLUTION	Azurity	1 VIAL in 1 CARTON (24338-056-01) / 1 mL...	200 mg/mL	200	$259.20	—	● Active	CMS ASP

NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

⚠️ Don't confuse J1072 with… RELATED CODES

Adjacent HCPCS codes that share an ingredient or formulation with J1072. Billing units and payment limits differ — confirm the exact code, strength and form before billing.

Code	Descriptor	Billing unit	Payment limit / unit	How it differs from J1072
J3145	Testosterone undecanoate 1mg	1 MG	$2.149	Related ingredient or formulation — confirm strength, form and billing unit before substituting.
J1071	Inj testosterone cypionate	1 MG	$0.025	Related ingredient or formulation — confirm strength, form and billing unit before substituting.
J3121	Inj testostero enanthate 1mg	1 MG	$0.053	Related ingredient or formulation — confirm strength, form and billing unit before substituting.

Related codes matched on shared ingredient (CMS Medicare Part B Spending feed). Billing units and payment limits from the CMS ASP Pricing File. Always verify the precise HCPCS code for the product and strength administered.

📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)

Period

Total Part B spend

$2.7K

Claims

46

Beneficiaries

19

Spend / beneficiary

$139.75

Spend / claim

$57.72

Trend by period

Where J1072 ranks among Part B drugs · 2026 (Q1) · neighbors ±5

Total spending — #736 of 824

#731 PAMIDRONATE DISODIUM J2430 $3K #732 LEVOFLOXACIN-D5W J1956 $2.9K #733 CLEOCIN PHOSPHATE* J0736 $2.8K #734 MANNITOL(J2151) J2151 $2.8K #735 CHLOROTHIAZIDE SODIU... J1205 $2.7K #736 AZMIRO J1072 $2.7K #737 DIPYRIDAMOLE J1245 $2.6K #738 PROCHLORPERAZINE EDI... J0780 $2.5K #739 PREDNISOLONE SODIUM... J7510 $2.4K #740 BCG (TICE STRAIN)(90... 90586 $2.4K #741 DEXTROSE 5%-0.9% NAC... J7042 $2.4K

Total claims — #701 of 824

#696 SYNOJOYNT, INJ., 1 M... J7331 50 #697 DDAVP* J2597 49 #698 YESINTEK Q5100 49 #699 ENVERSE, PER SQ CM** Q4258 47 #700 COMIRNATY (5-11Y)* 91319 46 #701 AZMIRO J1072 46 #702 AMPHADASE J3470 45 #703 MYLOTARG J9203 45 #704 PREMARIN J1410 44 #705 DERM-MAXX, PER SQ CM... Q4238 44 #706 ABILIFY ASIMTUFII J0402 43

Full breakdown by period (2)

Period	Total spend	Beneficiaries	Claims	$/beneficiary	$/claim
2026 (Q1)	$2.7K	19	46	$139.75	$57.72
2025 (Q1-Q4)	$6.5K	29	94	$222.48	$68.64

Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.

📈 Medicare Part B claims detail CMS PSPS · 2024

Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.

Allowed charges

$294.16

Medicare paid

$248.34

Submitted services

1,499

Denial rate

73.4%

Allowed / service

$0.74

Submitted charges

$4.3K

Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.

📊 What bills under J1072

J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.

NDC products by ingredient

TESTOSTERONE CYPIONATE 1

NDC products by labeler

Azurity Pharmaceuticals, Inc. 1

🔗 Related NDC directory pages

🧪 All Testosterone Cypionate NDCsIngredient 🏭 All Azurity labeler NDCsLabeler 24338 📚 All Androgen NDCsDrug class

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.

HCPCS code & descriptor

CMS HCPCS Level II code file

Not available in current dataset

Payment limit & billing unit

CMS Medicare Part B ASP Pricing File (quarterly)

Q3 2026 · as of 2026-08-20

NDC ↔ HCPCS crosswalk

CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)

2 NDCs mapped

NADAC acquisition cost

CMS National Average Drug Acquisition Cost (weekly)

Not available for mapped NDCs

Utilization & spend

CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners

Latest data year 2026

Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J1072 billing FAQ

What is HCPCS code J1072?

J1072 is a HCPCS Level II J-code used to bill Inj, testosterone, azmiro under Medicare Part B and most medical (not pharmacy) benefits.

What is the billing unit for J1072?

One unit of J1072 represents 1 MG. Report the number of units equal to the dose administered divided by 1 MG.

How many units of J1072 should I bill?

Divide the dose administered by the code's unit size (1 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.

How much does Medicare pay for J1072?

The Medicare Part B payment limit is $1.296 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $1.270 per unit. Payment limits are revised quarterly.

Which NDCs bill under J1072?

2 NDCs currently map to J1072 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.

Does a crosswalk mean J1072 is covered?

No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.

J1072 – Inj, testosterone, azmiro · NDC Crosswalk & Billing Units